Imagine a disease so sneaky that it fundamentally challenges what scientists once thought about coronaviruses—particularly how they interact with the immune system. And it’s not just a story about cats; it could reshape our understanding of long-lasting viral illnesses in humans. But here’s where it gets controversial: new research from the University of California, Davis reveals that a deadly feline coronavirus, responsible for a severe disease called feline infectious peritonitis (FIP), infects far more immune cells than previously believed. This could be a game-changer in understanding chronic inflammation and persistent viral infections like long COVID.
FIP is caused by a type of feline coronavirus that undergoes dangerous changes inside some cats, turning deadly if left untreated. While this disease targets only cats, its underlying mechanisms resemble those of serious human coronavirus illnesses, including the persistent inflammation and multi-organ damage seen in severe COVID-19 cases. Symptoms can linger or reappear even after initial recovery, prompting scientists to explore the role of the immune system in maintaining or fighting the infection.
For years, the dominant idea was that FIP’s virus mainly infected a specific kind of immune cell—certain lymphocytes. However, lead researcher Amir Kol from UC Davis’s School of Veterinary Medicine states, “What we discovered is that the virus actually infects a wider variety of immune cells, some of which are crucial for defending the body against infections.” The scientists analyzed lymph node samples from naturally infected cats—important because lymph nodes serve as decision hubs for immune cells. They found evidence of the virus inside multiple cell types, including B cells (which produce antibodies) and T cells (key players in identifying and destroying infected cells).
Even more eye-opening, the team observed that the virus was actively replicating within these immune cells—not just accidentally left behind or in a dormant state. This suggests that the infection isn’t just a fleeting event but could persist in the immune system, potentially leading to ongoing immune dysregulation.
So, why does this matter beyond our feline friends? In humans, similar persistent viral activity may explain why some individuals suffer from prolonged symptoms or immune disturbances long after the initial infection clears. However, studying this process directly in people is tremendously challenging because access to vital tissues like lymph nodes is limited. Fortunately, cats with FIP provide a rare, real-world opportunity to observe these mechanisms at close range.
According to Kol, “Cats give us a unique window into how coronaviruses can manipulate immune tissues during natural infection, something that’s extremely hard to study in humans.” Interestingly, the research also showed traces of the virus lingering inside immune cells even after antiviral treatments and when the cats appeared symptom-free. This lingering presence, especially in long-lived immune cells, could shed light on why some diseases relapse or why immune systems remain compromised long after initial infection.
This insight positions FIP as an invaluable model for studying long-term coronavirus effects—further linking veterinary and human medicine. The hope is that understanding how these viruses interact with the immune system over extended periods can guide us toward better treatments for chronic inflammatory conditions, including long COVID.
This groundbreaking research was conducted by a team of experts from UC Davis—including authors Aadhavan Balakumar, Patrawin Wanakumjorn, Kazuto Kimura, Ehren McLarty, Katherine Farrell, and others—and received funding from prestigious institutions like the National Institutes of Health, the Sock-FIP Fund, and Kasetsart University in Thailand. Ultimately, by investigating naturally occurring diseases in animals, scientists are unlocking clues that could significantly impact human health and the way we approach persistent viral infections.
